R M Drip and Sprinklers Systems Limited (NSE:RMDRIP)
India · Delayed Price · Currency is INR 675.75
-13.70 (-1.99%)
At close: Aug 6, 2025, 3:30 PM IST
Verve Therapeutics Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 1,312 | 502.69 | 109.54 | 179.16 | 182.14 | Upgrade |
Other Revenue | -0 | 0 | 15.39 | - | - | Upgrade |
| 1,312 | 502.7 | 124.93 | 179.16 | 182.14 | Upgrade | |
Revenue Growth (YoY) | 160.97% | 302.38% | -30.27% | -1.64% | -21.62% | Upgrade |
Cost of Revenue | 751.75 | 302.03 | 81.54 | 110.51 | 86.68 | Upgrade |
Gross Profit | 560.16 | 200.66 | 43.39 | 68.64 | 95.46 | Upgrade |
Selling, General & Admin | 56.05 | 30.08 | 11.21 | 19.43 | 18.86 | Upgrade |
Other Operating Expenses | 137.72 | 82.35 | 26.36 | 40.84 | 56.75 | Upgrade |
Operating Expenses | 218.93 | 123.79 | 46.47 | 71.41 | 87.25 | Upgrade |
Operating Income | 341.22 | 76.87 | -3.08 | -2.76 | 8.21 | Upgrade |
Interest Expense | -17.79 | -3.5 | -7.99 | -9.11 | -8.35 | Upgrade |
Interest & Investment Income | - | 0.81 | 0.17 | 0.14 | 0.15 | Upgrade |
Other Non Operating Income (Expenses) | - | - | 11.68 | 6.72 | 2.91 | Upgrade |
EBT Excluding Unusual Items | 323.44 | 74.18 | 0.77 | -5.02 | 2.91 | Upgrade |
Legal Settlements | - | -2.82 | - | - | - | Upgrade |
Pretax Income | 323.44 | 71.35 | 0.77 | -5.02 | 2.91 | Upgrade |
Income Tax Expense | 82.64 | 17.25 | 0.49 | 4.41 | 1.83 | Upgrade |
Earnings From Continuing Operations | 240.8 | 54.1 | 0.29 | -9.43 | 1.09 | Upgrade |
Minority Interest in Earnings | -0.75 | - | - | - | - | Upgrade |
Net Income | 240.05 | 54.1 | 0.29 | -9.43 | 1.09 | Upgrade |
Net Income to Common | 240.05 | 54.1 | 0.29 | -9.43 | 1.09 | Upgrade |
Net Income Growth | 343.69% | 18620.76% | - | - | -96.12% | Upgrade |
Shares Outstanding (Basic) | 24 | 12 | 7 | 7 | 7 | Upgrade |
Shares Outstanding (Diluted) | 24 | 21 | 7 | 7 | 7 | Upgrade |
Shares Change (YoY) | 12.60% | 218.36% | - | - | - | Upgrade |
EPS (Basic) | 10.01 | 4.45 | 0.04 | -1.41 | 0.16 | Upgrade |
EPS (Diluted) | 10.01 | 2.54 | 0.04 | -1.41 | 0.16 | Upgrade |
EPS Growth | 294.09% | 6250.00% | - | - | -96.12% | Upgrade |
Free Cash Flow | -390.38 | -199.45 | -19.39 | 9.36 | 10.29 | Upgrade |
Free Cash Flow Per Share | -16.28 | -9.37 | -2.90 | 1.40 | 1.54 | Upgrade |
Dividend Per Share | 0.500 | - | - | - | - | Upgrade |
Gross Margin | 42.70% | 39.92% | 34.73% | 38.31% | 52.41% | Upgrade |
Operating Margin | 26.01% | 15.29% | -2.47% | -1.54% | 4.51% | Upgrade |
Profit Margin | 18.30% | 10.76% | 0.23% | -5.27% | 0.60% | Upgrade |
Free Cash Flow Margin | -29.76% | -39.68% | -15.52% | 5.22% | 5.65% | Upgrade |
EBITDA | 366.39 | 88.15 | 5.82 | 8.37 | 19.79 | Upgrade |
EBITDA Margin | 27.93% | 17.54% | 4.66% | 4.67% | 10.87% | Upgrade |
D&A For EBITDA | 25.16 | 11.28 | 8.9 | 11.14 | 11.58 | Upgrade |
EBIT | 341.22 | 76.87 | -3.08 | -2.76 | 8.21 | Upgrade |
EBIT Margin | 26.01% | 15.29% | -2.47% | -1.54% | 4.51% | Upgrade |
Effective Tax Rate | 25.55% | 24.18% | 62.66% | - | 62.68% | Upgrade |
Revenue as Reported | 1,319 | 534.16 | 138.2 | 186.09 | 186.46 | Upgrade |
Advertising Expenses | - | 0.64 | 0.06 | - | 0.02 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.